GCIA
PTLA

Gabelli & Co Investment Advisers’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-521,822
Closed -$9.39M – 275
2020
Q2 		$9.39M Buy
+521,822
New +$7.26M 2.14% 13

Gabelli & Co Investment Advisers's PTLA Position: Q3 2020 in Review

Gabelli & Co Investment Advisers sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 521,822 shares — an estimated $9.39M sold.

Gabelli & Co Investment Advisers first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $9.39M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Gabelli & Co Investment Advisers reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 521,822 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $9.39M.
  • Gabelli & Co Investment Advisers first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Portola Pharmaceuticals, Inc. position peaked at $9.39M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2020, filed 6 Nov 2020.